Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design

Inhibition of aromatase (CYTP450) as a key enzyme in the estrogen biosynthesis could result in regression of estrogen-dependent tumors and even preventing the promotion of breast cancer. Although today potent steroid and non-steroid inhibitors of aromatase are available, isoflavanone derivatives as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaie, Sako, Chupani, Latifeh, Asadabadi, Ebrahim Barzegari, Shahverdi, Ahmad Reza, Jamalan, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531781/
https://www.ncbi.nlm.nih.gov/pubmed/26417225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531781/
https://www.ncbi.nlm.nih.gov/pubmed/26417225

Ejemplares similares